Canada Markets closed

Lobe Sciences Ltd. (LOBE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0250-0.0050 (-16.67%)
At close: 10:50AM EST
Full screen
Previous Close0.0300
Bid0.0300 x N/A
Ask0.0350 x N/A
Day's Range0.0250 - 0.0300
52 Week Range0.0250 - 0.2700
Avg. Volume195,977
Market Cap5.616M
Beta (5Y Monthly)3.81
PE Ratio (TTM)N/A
EPS (TTM)-0.0530
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Lobe Sciences to Present At H.C. Wainwright BIOCONNECT Investment Conference

    Vancouver, British Columbia--(Newsfile Corp. - January 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present at the H.C. Wainwright BIOCONNECT Conference taking place January 10-14, 2022.The presentation will be available on demand through the H.C. Wainwright conference portal, beginning at 7:00 a.m. ET on Monday, January 10, 2022. Registration for the event is accessible via

  • Newsfile

    Lobe Sciences Announces Publication of PCT Patent Application for Its Combination Therapy for mTBI and PTSD

    "Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder" Vancouver, British Columbia--(Newsfile Corp. - December 21, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") is pleased to announce its patent-pending therapeutic regimen that has been designed for treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder, and Mild Traumatic Brain

  • Baystreet

    Stocks in play: Lobe Sciences Ltd

    Announced that it has received approval from OTC Markets Group Inc. for its shares to trade on the OTCQB®. ...